What is the ticker symbol for Reviva Pharmaceuticals?

Reviva Pharmaceuticals trades under the ticker RVPHW on NASDAQ.

What sector does Reviva Pharmaceuticals operate in?

Reviva Pharmaceuticals is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze RVPHW in a portfolio?

PortView shows RVPHW's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Reviva Pharmaceuticals (RVPHW) Stock Analysis

NASDAQHealthcareBiotechnology

$0.00-16.67%

1-year price historyRange $0.00 – $0.50

52-week range$0.00

$0.00$0.04

What Reviva Pharmaceuticals does

Reviva Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing innovative therapies for diseases with substantial unmet medical needs. Their pipeline targets disorders within the central nervous system, respiratory, cardiovascular, metabolic, and inflammatory disease categories. The company's leading drug candidate, brilaroxazine (RP5063), is currently in Phase III clinical trials for the treatment of schizophrenia. This compound has also completed Phase I trials for a diverse set of conditions, including bipolar disorder, major depressive disorder, attention-deficit/hyperactivity disorder, the behavioral and psychotic symptoms of dementia or Alzheimer's disease, Parkinson's disease psychosis, pulmonary arterial hypertension, and idiopathic pulmonary fibrosis. Furthermore, Reviva is advancing RP1208, which is in pre-clinical development for depression and obesity. Founded in 2018, the company is headquartered in Cupertino, California.

Key metrics

Market cap

$343,911

P/E (TTM)

-0.00

EPS (TTM)

$-0.88

Beta

-0.03

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$0.07

200-day avg

$0.07

52-week high

$0.04

52-week low

$0.00

CEO

Laxminarayan Bhat

ETFs linked to RVPHW

Broad-market and Healthcare sector ETFs an investor holding Reviva Pharmaceuticals is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how RVPHW fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze RVPHW in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Reviva Pharmaceuticals?: Reviva Pharmaceuticals trades under the ticker RVPHW on NASDAQ.
Which exchange is RVPHW listed on?: RVPHW is listed on NASDAQ.
What sector does Reviva Pharmaceuticals operate in?: Reviva Pharmaceuticals is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze RVPHW in a portfolio?: PortView shows RVPHW's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.